Aim: To evaluate the effectiveness and safety of the beta-adrenoblocker nebivolol in patients with mild and moderate essential hypertension.
Material And Methods: The trial enrolled 20 patients. 11 of them had mild and 9 moderate arterial hypertension (mean age 47.